Click here to view the Humana Medical Policy Updates Updates » January 2025 Humana Medical…

BCBS Federal Employee Program (FEP) Medical Policy Updates – September 2018
September 2018 BCBS Federal Employee Program (FEP) Medical Policy Updates:
- Actimmune
- Adcetris
- Afinitor
- Aldurazyme
- Aliqopa
- Amantadine Extended-Release
- ART Drugs
- Arzerra
- Avastin
- Bavencio
- Beleodaq
- Benlysta
- Blincyto
- Botox
- Calquence
- Caprelsa
- Cinqair
- Cometriq
- Compound High Dollar Limit
- Compounding Kits
- Cotellic
- Crysvita
- Cyramza
- Darzalex
- Diabetic Test Strips
- Doxylamine Pyridoxine
- Dupixent
- Elaprase
- Empliciti
- Enbrel
- Endari
- Erbitux
- Erivedge
- Erleada
- Erwinaze
- Eucrisa
- Evomela
- Evzio
- Exjade Jadenu
- Exondys 51
- Farydak
- Ferriprox
- Fluticasone Powder
- Gabapentin
- Gabapentin Powder
- Growth Hormone – Adult
- Halaven
- HCG Powder,Novarel, Pregnyl, Ovidrel
- Helixate FS
- HT3 Antagonists
- Humira
- Iclusig
- Idhifa
- IL-5 Antagonists (IgG1 kappa)
- Ilumya
- Imfinzi
- Imlygic
- Inlyta
- Insulin GLP-1 Combinations
- Intron A
- IR Opioid Combo Drugs
- Iressa
- Istodax
- Jakafi
- Jevtana
- Kadcyla
- Kalydeco
- Kepivance
- Keytruda
- Kyprolis
- Lartruvo
- Lenvima
- Leukine
- Lidocaine Patches
- Lonsurf
- Lutathera
- Luxturna
- Luzu
- Lyrica
- Marqibo
- Mekinist
- Mepsevii
- Myalept
- Mylotarg
- Naglazyme
- Nexavar
- Nilandron
- Ninlaro
- NK1 Antagonists
- Nuplazid
- Odomzo
- Onivyde
- Opdivo
- Opioid Cough Medications
- Orkambi
- Pomalyst
- Portrazza
- Proton Pump Inhibitors
- Provenge
- Pulmozyme
- Regranex
- Relenza
- Revlimid
- Rituxan
- Rituxan Hycela
- Rubraca
- Rydapt
- Sabril
- Savella
- SCIG
- Sensipar
- SGLT2 Inhibitors
- Stivarga
- Suboxone Drug Class
- Sylatron
- Symdeko
- Synribo
- Tafinlar
- Tagrisso
- Tamiflu
- Tarceva
- Targretin
- Tasigna
- Tecentriq
- Topical Products with Quantity Limits
- Treanda Bendeka
- Trogarzo
- Unituxin
- Valchlor
- Vectibix
- Velcade
- Venclexta
- Verzenio
- Vfend
- Vimizim
- Votrient
- Xalkori
- Xiaflex
- Xolair
- Xtandi
- Yervoy
- Yondelis
- Zaltrap
- Zejula
- Zelboraf
- Zilretta
- Zolinza
- Zydelig
- Zykadia
- Zytiga
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.